(Q39718620)

14 September 2017

title

RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells (English)

1 reference

14 September 2017

main subject

hepatocellular carcinoma

1 reference

1 reference

Yinghui Fu

1

1 reference

14 September 2017

Jian Huang

2

1 reference

14 September 2017

Ke-Sheng Wang

3

1 reference

14 September 2017

Xin Zhang

4

1 reference

14 September 2017

Ze-Guang Han

5

1 reference

14 September 2017

publication date

6 April 2010

1 reference

Molecular Biology Reports

14 September 2017

published in

1 reference

14 September 2017

volume

38

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

693-702

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-010-0156-5

14 September 2017

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Hepatocellular carcinoma: the need for progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Targeting cancer with small molecule kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Aurora kinases: new targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Aurora kinases as anticancer drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Aurora kinases as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

3-Hydroxyflavone inhibits endogenous Aurora B and induces growth inhibition of cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Role of citron kinase as a target of the small GTPase Rho in cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

ASPM and citron kinase co-localize to the midbody ring during cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Citron kinase, a Rho-dependent kinase, induces di-phosphorylation of regulatory light chain of myosin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Disruption of the Dictyostelium myosin heavy chain gene by homologous recombination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Citron kinase is a cell cycle-dependent, nuclear protein required for G2/M transition of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Rubella virus P90 associates with the cytokinesis regulatory protein Citron-K kinase and the viral infection and constitutive expression of P90 protein both induce cell cycle arrest following S phase in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Rubella virus and birth defects: molecular insights into the viral teratogenesis at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Citron kinase, a RhoA effector, enhances HIV-1 virion production by modulating exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Rho/Rho-kinase mediated signaling in physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Up-regulation of Tropomyosin related kinase B contributes to resistance to detachment-induced apoptosis in hepatoma multicellular aggregations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Citron rho-interacting kinase, a novel tissue-specific ser/thr kinase encompassing the Rho-Rac-binding protein Citron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Cell motility mediated by rho and rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Expression of ROCK-1 in human pancreatic cancer: its down-regulation by morpholino oligo antisense can reduce the migration of pancreatic cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

Essential role of citron kinase in cytokinesis of spermatogenic precursors

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11033-010-0156-5

21 January 2018

12 December 2020

Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases

1 reference

12 December 2020

Multidrug resistance gene (MDR-1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection

1 reference

12 December 2020

Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells

1 reference

12 December 2020

Construction of NF-κB-targeting RNAi adenovirus vector and the effect of NF-κB pathway on proliferation and apoptosis of vascular endothelial cells

1 reference

12 December 2020

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S11033-010-0156-5

Identifiers

DOI

1 reference

14 September 2017

1 reference